Biocon Q1FY23 Revenue at Rs 2,217 Cr, Up 23%; Net Profit at …

Biocon Q1FY23 Revenue At Rs 2,217 Cr, Up 23%; Net Profit At …

2 weeks from now

Biocon Q1FY23 Revenue at Rs 2,217 Cr, Up 23%; Net Profit at Rs 144 Cr, Up 71%; Core EBITDA at Rs 660 Cr Up 25% Biosimilars Up 29%; Generics Up 19%; Research Services Up …

biocon.com

Biocon Net Profit Rises 71% To Rs 144 Cr In June Quarter; Revenue …

2 weeks from now

Jul 27, 2022  · Biotechnology major Biocon on Wednesday reported a 71 per cent increase in consolidated net profit at Rs 144 crore for the June quarter on the back of robust growth …

business-standard.com

Q1FY23 Quarterly Result Announced For Biocon Ltd. - Trendlyne

2 weeks from now

Jul 28, 2022  · Biotechnology firm Biocon Announced Q1FY23 Result : Biocon Q1FY23 Revenue at Rs 2,217 Cr, Up 23%; Net Profit at Rs 144 Cr, Up 71%; Core EBITDA at Rs 660 Cr Up 25% …

trendlyne.com

Biocon Q1 Profit Drops 29.8% To Rs 101.40 Crore, Revenue Up 60

2 weeks from now

Aug 11, 2023  · Biocon Biologics Q1FY24 revenue was recorded at Rs 2015 crore, up 106 per cent from Rs 977 crore in Q1FY23, led by the strong performance of its key biosimilars in …

financialexpress.com

Biocon Q1FY23 Revenue Up 23% At Rs 2,217 Cr - Investing.com India

2 weeks from now

Jul 27, 2022  · Read Biocon Q1FY23 revenue up 23% at Rs 2,217 cr By IANS. Biocon Q1FY23 revenue up 23% at Rs 2,217 cr. Download the App. More markets insights, more alerts, more …

investing.com

Biocon’s Net Profit Rises 71 Percent To Rs 144.4 Crore In First Quarter

2 weeks from now

Jul 27, 2022  · “Biocon Biologics reported a year-on-year growth of 29% for Q1FY23 with revenues at Rs 977 Crore. Core EBITDA at Rs 361 Crore was up 33%, representing healthy margins of …

financialexpress.com

FY23 Revenue At Rs 11,550 Cr, Up 38%; EBITDA At Rs 2,888 Cr …

2 weeks from now

May 23, 2023  · Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% EBITDA at Rs ... FY23 Revenue at Rs 11,550 Cr, Up 38%; …

biocon.com

Biocon Biologics - Transforming Healthcare. Transforming Lives.

2 weeks from now

Jan 30, 2025  · Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7% # EBITDA at Rs 787 Cr, Up 16% #; Net Profit at Rs 25 Cr. Jan 30, 2025. Biocon’s S&P Global ESG Score Improves to 69 for …

bioconbiologics.com

Biocon Q1FY25 Revenue Up 30% At Rs 4,567 Cr EBITDA Up 117

2 weeks from now

Aug 8, 2024  · Financial Commentary: Q1FY25 . Total Consolidated Revenue for Q1FY25 grew 30% year-on-year (YoY) to Rs 4,567 crore.. Other Income includes proceeds of Rs 1,057 …

biocon.com

Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%

2 weeks from now

Jan 30, 2025  · Financial Commentary: Q3FY25. Consolidated Total Revenue for Q3FY25 was at Rs 3,856 crore.Reported 7% YoY growth on a like-for-like basis, after adjusting for Branded …

biocon.com

Biocon Q4FY23 Revenue At Rs 3,929 Cr, Up 59%; Biosimilars Up …

2 weeks from now

May 23, 2023  · Net Profit (before exceptional Items) at Rs 787 Cr, Up 9%. Bengaluru, Karnataka, India: May 23, 2023: Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global …

biocon.com

Biocon - India's Largest Biopharmaceutical Company

2 weeks from now

2 days ago  · Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7% # EBITDA at Rs 787 Cr, Up 16% #; Net Profit at Rs 25 Cr Thu, 30-Jan-2025 Details ... COVID-19 Response; Home; About Us; …

biocon.com

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Feb 14, 2023  · Q3FY23 revenue at Rs 786 Crore, up 23% (YoY) from Rs 641 Crore in Q3FY22. Business Performance. Syngene’s Q3FY23 results reflect positive performances across all …

biocon.com

Biocon Q3FY22 Revenue At Rs 2,223 Cr, Up 18%; EBITDA At Rs 537 …

2 weeks from now

Jan 20, 2022  · Biocon Q3FY22 Revenue at Rs 2,223 Cr, Up 18%; EBITDA at Rs 537 Cr, Up 25%; Biosimilars Up 28% at Rs 981 Cr; Research Services Up 10% at Rs 641 Cr; Generics Up 7% …

biocon.com